Medical science says a stent is needed only when the blockage in an artery is more than 80%. However, a recent ...

The data support endovascular therapy with stent implantation as an alternative to bypass surgery in men and women.

Numerous organizations are focusing on new product development for lacrimal duct stent tubes. In June 2019, FCI Ophthalmic ...

Reflow Medical has completed enrollment in a clinical trial evaluating its retrievable stent for the treatment of vascular ...

R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), announced today the ...

R3 Vascular announced today that it closed an $87 million Series B financing round and appointed Christopher Owens as ...

McMeans, a leader in Abbott’s vascular unit, discussed the company’s newly approved stent for the tough-to-treat condition in an interview with MedTech Dive.

Reflow Medical, Inc. announced the completion of enrollment in the DEEPER REVEAL clinical trial of the Reflow Spur stent.

In the PREVENT trial, researchers found that adding percutaneous coronary intervention to optimal medical treatment resulted in better patient outcomes.

A former OSF HealthCare doctor was found negligent in his actions when treating the 13-year-old in 2011 when she was an ...

An Illinois surgeon was found negligent by a jury last week for his treatment of a girl who went to the hospital for a choking episode in 2011.

A Peoria County jury found Dr. Mark J. Holterman negligent as a surgeon regarding his treatment of a now-13-year-old girl ...